1. Analysis of Real-World Data on Overall Survival in Multiple Myeloma Patients With ≥3 Prior Lines of Therapy Including a Proteasome Inhibitor (PI) and an Immunomodulatory Drug (IMiD), or Double Refractory to a PI and an IMiD. (2nd August 2016) Authors: Usmani, Saad; Ahmadi, Tahamtan; Ng, Yvette; Lam, Annette; Desai, Avinash; Potluri, Ravi; Mehra, Maneesha Journal: Oncologist Issue: Volume 21:Number 11(2016) Page Start: 1355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of Real‐World Data on Overall Survival in Multiple Myeloma Patients With ≥3 Prior Lines of Therapy Including a Proteasome Inhibitor (PI) and an Immunomodulatory Drug (IMiD), or Double Refractory to a PI and an IMiD. (2nd August 2016) Authors: Usmani, Saad; Ahmadi, Tahamtan; Ng, Yvette; Lam, Annette; Desai, Avinash; Potluri, Ravi; Mehra, Maneesha Journal: Oncologist Issue: Volume 21:Number 11(2016) Page Start: 1355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Avoidable Acute Care Use Associated with Nausea and Vomiting Among Patients Receiving Highly Emetogenic Chemotherapy or Oxaliplatin. (21st December 2020) Authors: Navari, Rudolph M.; Ruddy, Kathryn J.; LeBlanc, Thomas W.; Nipp, Ryan; Clark‐Snow, Rebecca; Schwartzberg, Lee; Binder, Gary; Bailey, William L.; Potluri, Ravi; Schmerold, Luke M.; Papademetriou, Eros; Roeland, Eric J. Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: 325 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Economic burden to commercial payers of young adults with schizophrenia in Colorado. (1st January 2021) Authors: Pesa, Jacqueline; Patel, Charmi; Rotter, David; Papademetriou, Eros; Potluri, Ravi; Benson, Carmela Journal: Journal of medical economics Issue: Volume 24:Number 1(2021) Page Start: 1194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. How well do clinical and demographic characteristics predict Patient Health Questionnaire‐9 scores among patients with treatment‐resistant major depressive disorder in a real‐world setting?. Issue 2 (5th January 2021) Authors: Voelker, Jennifer; Joshi, Kruti; Daly, Ella; Papademetriou, Eros; Rotter, David; Sheehan, John J.; Kuvadia, Harsh; Liu, Xing; Dasgupta, Anandaroop; Potluri, Ravi Journal: Brain and behavior Issue: Volume 11:Issue 2(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patient characteristics and outcomes after ruxolitinib discontinuation in patients with myelofibrosis. (2nd July 2020) Authors: Mascarenhas, John; Mehra, Maneesha; He, Jianming; Potluri, Ravi; Loefgren, Christina Journal: Journal of medical economics Issue: Volume 23:Number 7(2020) Page Start: 721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗